Good morning :)
$
₹
Hims Hers Health Inc

Hims Hers Health Inc

HIMS

NYSE
Asset Logo

Hims Hers Health Inc

HIMS

NYSE
$27.450.90% (-0.25)
$
₹
$27.450.90% (-0.25)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Drug Manufacturers - Specialty & Generic

Mid Cap

With a market cap of $6.5B the stock is ranked 1220

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

20.15
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.64
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

2.55
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-5.51%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 15 analysts reports

Buy
3 analysts
Hold
12 analysts
Sell
0 analyst

Price Upside

+12.43%

Earnings Growth

-152.36%

Rev. Growth

+36.65%

See Detailed Forecast

Company Profile

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
CVS Health Corp
CVS
CVS Health Corp
P/E Ratio
24.59
24.59
1Y Return
15.29%
15.29%
Buy Reco %
92.59
92.59
Cigna Corp
CI
Cigna Corp
P/E Ratio
12.68
12.68
1Y Return
0.61%
0.61%
Buy Reco %
75.00
75.00
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
P/E Ratio
24.09
24.09
1Y Return
32.01%
32.01%
Buy Reco %
52.94
52.94
Laboratory Corporation of America Holdings
LH
Laboratory Corporation of America Holdings
P/E Ratio
27.20
27.20
1Y Return
16.13%
16.13%
Buy Reco %
72.22
72.22
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
143.8%
143.8%
Buy Reco %
96.15
96.15
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Lower price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 12.43% growth, versus a trailing 3-year CAGR of 64.81%.

2026
Current$27.71Baseline
Analyst Target - 1 year
Target$31.15+12.43%

All values in $

202220232024202520262027$13.26$20.74$28.23Target+12.43%
2026
Current$27.71Baseline
Analyst Target - 1 year
Target$31.15+12.43%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 36.65% growth, versus a trailing 3-year CAGR of 64.55%.

2025
Current$2.34Baseline
Forecast for Dec 2026
High$3.30+40.93%
Average$3.20+36.65%
Low$3.15+34.27%

All values in $ Billion

2021202220232024202520260.270.520.871.472.34Low+34.27%Average+36.65%High+40.93%
2025
Current$2.34Baseline
Forecast for Dec 2026
High$3.30+40.93%
Average$3.20+36.65%
Low$3.15+34.27%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

2025
Current$1.07Baseline
Forecast for Dec 2026
High$-0.01-100.93%
Average$-0.56-152.36%
Low$-0.91-185.05%

All values in $

202120222023202420252026-0.62-0.320.150.81.07Low-185.05%Average-152.36%High-100.93%
2025
Current$1.07Baseline
Forecast for Dec 2026
High$-0.01-100.93%
Average$-0.56-152.36%
Low$-0.91-185.05%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

598.9
15.7
617.8
20.6
608.1
-92.1
753.2
-86.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue278.17315.64401.55481.13586.01544.83598.97617.81608.10753.21
Net Income11.1213.2975.5826.0249.4842.5015.7720.60-92.11-86.29
Net Profit Margin4.00%4.21%18.82%5.40%8.44%7.80%2.63%3.33%-15.14%-11.45%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - Specialty & Generic

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Hims Hers Health Inc -20.152.55
CVS Health Corp24.591.440.21
Cigna Corp12.681.710.75
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare HIMS with any stock or ETF
Compare HIMS with any stock or ETF
Comparing from
HIMS
CVS
CI
Loading...

Frequently asked questions

  1. Hims Hers Health Inc (HIMS) share price today is $27.45 as of October 27, 2026 at 12:08 AM IST. The stock touched a day high of $27.88 and a day low of $27.28.

  2. Hims Hers Health Inc stock trades on NYSE under the ticker symbol HIMS.

  3. Hims Hers Health Inc's market capitalization is $6.46B as of October 27, 2026 at 12:08 AM IST.

  4. Hims Hers Health Inc's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

  5. Hims Hers Health Inc's price-to-book (P/B) ratio is 20.15 as of October 26, 2026.

  6. Yes, You can buy Hims Hers Health Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Hims Hers Health Inc shares in three steps: 1. Search Hims Hers Health Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Hims Hers Health Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Hims Hers Health Inc (HIMS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3641 shares at the current price of $27.45.

Loading...